CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...

The rescinded Biden-era orders include actions to boost the Affordable Care Act exchanges, coordinate the government’s ...

The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the Inflation Reduction Act.

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The University of New Hampshire Franklin Pierce School of Law is expanding its focus on specialized legal education with the ...

The innovative MicroCNX® Nano Series connectors help maintain sterility in CGT processes using 1/8- or 1/16-inch tubing and ...

Four of the top 10 drugs by prescription sales in 2025 will be from the new incretin class, according to the latest analysis by Evaluate. Consensus forecasts for Ozempic, Wegovy, Mounjaro and Zepbound ...

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...